Pokrovskiĭ A G, Fediuk N V, Rzhanninova A A, Garaev M M
Vopr Virusol. 1995 Jan-Feb;40(1):8-12.
Enzyme-linked immunosorbent assay (ELISA) test-system for HIV-1 p24 antigen detection in human blood specimens has been developed. Use of complex biotin-streptavidin-horseradish peroxidase conjugate increased the sensitivity of the method to 50 pg/ml. The test system is characterized by 100 percent specificity, whereas direct p24 assay detects the antigen in only 5 percent of 100 sera of HIV-infected patients, since even low-titer sera efficiently mask p24. In order to extend the use of the test-system, destruction of immune complexes by different methods has been undertaken in experiments with different HIV-1 strains (RF, BRU). Acid hydrolysis detected the antigen in 30% of samples, appreciably improving the prognostic value of the test-system. A manifest correlation was revealed between the frequency of p24 detection in the blood plasma and clinical diagnosis.
已开发出用于检测人血标本中HIV-1 p24抗原的酶联免疫吸附测定(ELISA)测试系统。使用生物素-链霉亲和素-辣根过氧化物酶复合物可将该方法的灵敏度提高到50 pg/ml。该测试系统具有100%的特异性,而直接p24检测仅在100例HIV感染患者的血清中有5%能检测到抗原,因为即使是低滴度血清也能有效掩盖p24。为了扩大该测试系统的应用,在对不同HIV-1毒株(RF、BRU)进行的实验中采用了不同方法破坏免疫复合物。酸水解在30%的样本中检测到了抗原,显著提高了该测试系统的预后价值。血浆中p24检测频率与临床诊断之间存在明显相关性。